Back to Search
Start Over
64 (PB054) - BDTX-1535, a fourth generation EGFR inhibitor, targeting intrinsic and acquired resistance mutations in NSCLC.
- Source :
-
European Journal of Cancer . 2022 Supplement 1, Vol. 174, pS22-S22. 1p. - Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 09598049
- Volume :
- 174
- Database :
- Academic Search Index
- Journal :
- European Journal of Cancer
- Publication Type :
- Academic Journal
- Accession number :
- 159857207
- Full Text :
- https://doi.org/10.1016/S0959-8049(22)00862-0